hcplive podcasts

Peers & Perspectives

EP. 1: Diagnosis of Heart Failure (HF)

EP. 2: Role of Early Treatment and Gaps in Heart Failure Diagnosis

EP. 3: Heart Failure Treatment in the Healthcare System

EP. 4: ACC Expert Consensus Decision Pathway for HF Treatment

EP. 5: Evolution of Heart Failure Treatments

EP. 6: Using Sacubitril/Valsartan in Heart Failure Treatment

EP. 7: Considering ARNIs as De Novo Therapy in Heart Failure

EP. 8: Target Dose in HF Therapies for Reduced Ejection Fraction

EP. 1: ADA Clinical Guideline Overview for Diabetes

EP. 2: New Available Treatment Options for Type 2 Diabetes

EP. 3: Patient Factors and CV Risk in Type 2 Diabetes

EP. 4: GLP-1 Receptor Agonist Treatment Options for T2D

EP. 5: Management of Nausea Resulting from GLP1 Agonists for T2DM

EP. 6: GLP1 Receptor Agonists in Clinical Practice for T2DM

EP. 7: Underutilization of GLP1 Receptor Agonists in T2DM Therapy

EP. 8: Management of T2DM During COVID and Future Directions

EP. 1: Progressive Nature and Severity of Rheumatic Diseases

EP. 2: Take-Home Messages from ACR 2020: Psoriatic Arthritis

EP. 3: Take-Home Messages from ACR 2020: Behcet’s Disease

EP. 4: Expert Perspectives on Management of Rheumatic Diseases: Post ACR Convergence 2020

EP. 1: Clinical Manifestations of Psoriatic Diseases

EP. 2: Triggers of Joint Disease

EP. 3: Psoriatic Arthritis: Physical and Social Burdens

EP. 4: Challenges in the Management of Psoriatic Arthritis

EP. 5: Assessing Individual Patient Needs With Plaque Psoriasis

EP. 6: Standard of Care: Psoriatic Arthritis and Plaque Psoriasis

EP. 7: Using Oral Systemic Agents for Psoriatic Arthritis Treatment

EP. 8: Treatment of Psoriatic Arthritis With Nonbiologic Agents

EP. 9: TNF Blockers as First-Line Therapy for Psoriatic Disease

EP. 10: IL-17, IL-23 Blockers for Treatment of Plaque Psoriasis

EP. 11: Looking Toward the Future in Plaque Psoriasis

EP. 12: Optimizing Care With a Multidisciplinary Approach

EP. 13: Approaching Treatment for Patients With Psoriatic Arthritis

EP. 1: Concerns Surrounding Increasing Rates of Inflammatory Bowel Disease

EP. 2: COVID-19 and Inflammatory Bowel Disease

EP. 3: Anticytokine Therapy for IBD and COVID-19

EP. 4: Optimizing Therapy for IBD During COVID-19

EP. 5: Telemedicine to Monitor Patients With IBD During COVID-19

EP. 6: Inflammatory Bowel Disease: Treatment Advances

EP. 7: Managing IBD With Anti-TNF Therapy

EP. 8: Vedolizumab and Ustekinumab for IBD

EP. 9: IBD Treatment: Translating Data Into Clinical Practice

EP. 10: Inflammatory Bowel Disease: Limitations in Treatment

EP. 11: Inflammatory Bowel Disease: Initiating Therapy

EP. 12: Switching Between Biologics in Inflammatory Bowel Disease

EP. 13: Navigating IBD During the Coronavirus Pandemic

EP. 1: Pathophysiology of T2DM and Cardiovascular Disease

EP. 2: T2DM Management: Endocrinologist or Local Physician?

EP. 3: Available Treatments for Type 2 Diabetes

EP. 4: Ensuring an Accurate Diagnosis of T2DM

EP. 5: Ongoing Trials and Lifestyle Changes

EP. 6: The Collaborative Management of T2DM

EP. 7: Advice for Cardiologists Managing T2DM

EP. 8: The Future of T2DM Management

x